American urological association guideline on the management of priapism

Journal of Urology

Volumn 170, Issue 4 I, 2003, Pages 1318-1324

  Montague, Drogo K ^a   Jarow, Jonathan ^a   Broderick, Gregory A ^a   Dmochowski, Roger R ^a   Heaton, Jeremy P W ^a   Lue, Tom F ^a   Nehra, Ajay ^a   Sharlip, Ira D ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIANDROGEN; EPHEDRINE; GONADORELIN AGONIST; METARAMINOL; NORADRENALIN; PHENYLEPHRINE; TERBUTALINE; VASODILATOR AGENT;

ALGORITHM; ARTIFICIAL EMBOLISM; ASPIRATION; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DISEASE ASSOCIATION; DRUG EFFICACY; ERECTILE DYSFUNCTION; HORMONAL THERAPY; HUMAN; LAVAGE; MEDICAL SOCIETY; PATHOPHYSIOLOGY; PENILE BLOOD FLOW; PENILE FIBROSIS; PRACTICE GUIDELINE; PRIAPISM; PRIORITY JOURNAL; REVIEW; SHUNTING; SIDE EFFECT;

EID: 0042191729     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000087608.07371.ca     Document Type: Article

References (25)

1. El-Bahnasawy, M. S., Dawood, A. and Farouk, A.: Low-flow priapism: risk factors for erectile dysfunction. BJU Int, 89: 285, 2002
2. Spycher, M. A. and Hauri, D.: The ultrastructure of erectile tissue in priapism. J Urol, 135: 142, 1986
3. Broderick, G. A. and Harkaway, R.: Pharmacologic erection: time-dependent changes in the corporal environment. Int J Impot Res, 6: 9, 1994
4. Hoffman, B.: Catecholamines, sympathomimetic drugs, and adrenergic receptor antagonists. In: Goodman and Gilman's The Pharmacological Basis of Therapeutics. Edited by J. G. Hardman, L. E. Limbird and A. G. Gilman. New York: McGraw-Hill Professional Publishing, chapt. 10, pp. 215-268, 2001
5. Nitahara, K. S. and Lue, T. F.: Priapism. In: Glenn's Urologic Surgery. Edited by S. D. Graham, Jr., J. F. Glenn and C. C. Carson. Philadelphia: Lippincott Williams & Wilkins, 1998
6. Hinman, F., Jr., Donley, S. and Stempen, P. H.: Atlas of Urologic Surgery, 2nd ed. Philadelphia: W. B. Saunders Co., sect. 6, pp. 177-228, 1998
7. Kulmala, R. V., Lehtonen, T. A., Lindholm, T. S. and Tammela, T. L.: Permanent open shunt as a reason for impotence or reduced potency after surgical treatment of priapism in 26 patients. Int J Impot Res, 7: 175, 1995
8. Ochoa Urdangarain, O. and Hermida Perez, J. A.: Priapism. Our experience. Arch Esp Urol, 51: 269, 1998
9. Kandel, G. L., Bender, L. I. and Grove, J. S.: Pulmonary embolism: a complication of corpus-saphenous shunt for priapism. J Urol, 99: 196, 1968
10. Lowe, F. C. and Jarow, J. P.: Placebo-controlled study of oral terbutaline and pseudoephedrine in management of prostaglandin E1-induced prolonged erections. Urology, 42: 51, 1993
11. Seftel, A. D., Haas, C. A., Brown, S. L., Herbener, T. E., Sands, M. and Lipuma, J.: High flow priapism complicating veno-occlusive priapism: pathophysiology of recurrent idiopathic priapism? J Urol, 159: 1300, 1998
12. Matson, S., Herndon, C. D. A. and Honig, S. C.: Pathophysiology of "low flow" priapism: intermediate phase-evidence of "high flow" defined with duplex ultrasound. Int J Impot Res, 11: S27, 1999
13. Bastuba, M. D., Saenz de Tejada, I., Dinlenc, C. Z., Sarazen, A., Krane, R. J. and Goldstein, I.: Arterial priapism: diagnosis, treatment and long-term followup. J Urol, 151: 1231, 1994
14. Steers, W. D. and Selby, J. B., Jr.: Use of methylene blue and selective embolization of the pudendal artery for high flow priapism refractory to medical and surgical treatments. J Urol, 146: 1361, 1991
15. Gbadoe, A. D., Assimadi, J. K. and Segbena, Y. A.: Short period of administration of diethylstilbestrol in stuttering priapism in sickle cell anemia. Am J Hematol, 69: 297, 2002
16. Virag, R., Bachir, D., Lee, K. and Galacteros, F.: Preventive treatment of priapism in sickle cell disease with oral and self-administered intracavernous injection of etilefrine. Urology, 47: 777, 1996
17. Dahm, P., Rao, D. S. and Donatucci, C. F.: Antiandrogens in the treatment of priapism. Urology, 59: 138, 2002
18. Levine, L. A. and Guss, S. P.: Gonadotropin-releasing hormone analogues in the treatment of sickle cell anemia-associated priapism. J Urol, 150: 475, 1993
19. Serjeant, G. R., de Ceulaer, K. and Maude, G. H.: Stilboestrol and stuttering priapism in homozygous sickle-cell disease. Lancet, 2: 1274, 1985
20. Steinberg, J. and Eyre, R. C.: Management of recurrent priapism with epinephrine self-injection and gonadotropin-releasing hormone analogue. J Urol, 153: 152, 1995
21. Rourke, K. F., Fischler, A. H. and Jordan, G. H.: Treatment of recurrent idiopathic priapism. J Urol, 168: 2552, 2002
22. Gupta, S., Salimpour, P., Saenz de Tejada, I., Daley, J., Gholami, S., Daller, M. et al: A possible mechanism for alteration of human erectile function by digoxin: inhibition of corpus cavernosum sodium/potassium adenosine triphosphatase activity. J Urol, 159: 1529, 1998
23. Ahmed, I. and Shaikh, N. A.: Treatment of intermittent idiopathic priapism with oral terbutaline. Br J Urol, 80: 341, 1997
24. Gbadoe, A. D., Atakouma, Y., Kusiaku, K. and Assimadi, J. K.: Management of sickle cell priapism with etilefrine. Arch Dis Child, 85: 52, 2001
25. Van Driel, M. F., Joosten, E. A. and Mensink, H. J.: Intracorporeal self-injection with epinephrine as treatment for idiopathic recurrent priapism. Eur Urol, 17: 95, 1990